405 related articles for article (PubMed ID: 32162734)
41. A CD44-targeted Cu(ii) delivery 2D nanoplatform for sensitized disulfiram chemotherapy to triple-negative breast cancer.
Gao Z; Li Y; Zhang Y; An P; Chen F; Chen J; You C; Wang Z; Sun B
Nanoscale; 2020 Apr; 12(15):8139-8146. PubMed ID: 32236229
[TBL] [Abstract][Full Text] [Related]
42. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383
[TBL] [Abstract][Full Text] [Related]
43. The combination of disulfiram and copper for cancer treatment.
Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
[TBL] [Abstract][Full Text] [Related]
44. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
[TBL] [Abstract][Full Text] [Related]
45. Construction Of High Loading Natural Active Substances Nanoplatform and Application in Synergistic Tumor Therapy.
Liu H; Jiapaer Z; Meng F; Wu W; Hou C; Duan M; Qin Y; Shao S; Zhang M
Int J Nanomedicine; 2022; 17():2647-2659. PubMed ID: 35730051
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry.
Lu X; Lin B; Xu N; Huang H; Wang Y; Lin JM
Talanta; 2020 May; 211():120732. PubMed ID: 32070566
[TBL] [Abstract][Full Text] [Related]
47. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
[TBL] [Abstract][Full Text] [Related]
48. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.
Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z
Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421
[TBL] [Abstract][Full Text] [Related]
49. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
[TBL] [Abstract][Full Text] [Related]
50. Ultra-small Bi
Ren C; Cheng Y; Li W; Liu P; Yang L; Lu Q; Xu M; Tan F; Li J; Li N
Biomater Sci; 2020 Mar; 8(7):1981-1995. PubMed ID: 32068203
[TBL] [Abstract][Full Text] [Related]
51. Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.
Zhou L; Yang L; Yang C; Liu Y; Chen Q; Pan W; Cai Q; Luo L; Liu L; Jiang S; He H; Zhang Y; Yin T; Tang X
Pharm Res; 2018 May; 35(7):147. PubMed ID: 29796711
[TBL] [Abstract][Full Text] [Related]
52. An Endogenous H
Chen J; Xue F; Du W; Yu H; Yang Z; Du Q; Chen H
Nano Lett; 2022 Aug; 22(15):6156-6165. PubMed ID: 35852844
[TBL] [Abstract][Full Text] [Related]
53. Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas.
Li Y; Fu SY; Wang LH; Wang FY; Wang NN; Cao Q; Wang YT; Yang JY; Wu CF
Cancer Lett; 2015 Dec; 369(1):86-96. PubMed ID: 26254539
[TBL] [Abstract][Full Text] [Related]
54. Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy.
Qu Y; Li A; Ma L; Iqbal S; Sun X; Ma W; Li C; Zheng D; Xu Z; Zhao Z; Ma D
Int J Pharm; 2021 Mar; 597():120250. PubMed ID: 33486040
[TBL] [Abstract][Full Text] [Related]
55. Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.
Fu G; Liu W; Feng S; Yue X
Chem Commun (Camb); 2012 Dec; 48(94):11567-9. PubMed ID: 23090583
[TBL] [Abstract][Full Text] [Related]
56. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
[TBL] [Abstract][Full Text] [Related]
57. Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu
Hu H; Cui L; Lu J; Wei K; Wei J; Li S; Zou C; Chen T
Cancer Med; 2020 Sep; 9(18):6791-6801. PubMed ID: 32750218
[TBL] [Abstract][Full Text] [Related]
58. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells.
Cen D; Brayton D; Shahandeh B; Meyskens FL; Farmer PJ
J Med Chem; 2004 Dec; 47(27):6914-20. PubMed ID: 15615540
[TBL] [Abstract][Full Text] [Related]
59. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint.
Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z
Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028
[TBL] [Abstract][Full Text] [Related]
60. Disulfiram Chelated with Copper Promotes Apoptosis in Osteosarcoma via ROS/Mitochondria Pathway.
Ren Y; Lin Y; Chen J; Jin Y
Biol Pharm Bull; 2021; 44(10):1557-1564. PubMed ID: 34602566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
